Prosecution Insights
Last updated: November 20, 2026
Application No. 18/489,378

POLYISOPRENE LATEX GRAPHENE COMPOSITES AND METHODS OF MAKING THEM

Non-Final OA §102§103§112§DOUBLEPATENT
Filed
Oct 18, 2023
Priority
Nov 03, 2016 — MA PI2016001937 +3 more
Examiner
CAI, WENWEN
Art Unit
1763
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Karex Holdings Sdn Bhd
OA Round
5 (Non-Final)
60%
Grant Probability
Moderate
5-6
OA Rounds
1m
Est. Remaining
79%
With Interview

Examiner Intelligence

Grants 60% of resolved cases
60%
Career Allowance Rate
531 granted / 889 resolved
-5.3% vs TC avg
Strong +20% interview lift
Without
With
+19.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
65 currently pending
Career history
970
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
44.9%
+4.9% vs TC avg
§102
17.3%
-22.7% vs TC avg
§112
28.8%
-11.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 889 resolved cases

Office Action

§102 §103 §112 §DOUBLEPATENT
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Amendment The amendment of claims 20, 24-25 are supported by the specification. Any rejections and/or objections made in the previous Office action and not repeated below are hereby withdrawn. The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. The new grounds of rejection set forth below are necessitated by applicant's amendment filed on 12/19/2025. Thus, the following action is properly made final. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), first paragraph: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claim 33 rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for pre-AIA the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 33 recites “the reduced graphene oxide composition is present in an amount of from 0.01 to about 1.0 phr”. The specification discloses the amount of graphene oxide in the composite composition is from about 0.01 to 1.0 phr. The specification does not support a composition comprising both graphene oxide and curing agents in an amount of 0.01-1 phr. Claim Rejections - 35 USC § 102 Claim(s) 20-23, 25, 28, 30-31 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Gao et al (CN105906854). It is noted that “the reduced graphene oxide composition comprises a product of a reduction reaction involving graphene oxide and a combination of curing agents” is a product-by-process limitation. It does not specify the role of the combination of curing agents: a reagent, a catalyst, or just presents when the reaction occurs. Given the broadest reasonable claim interpretation, a mixture of reduced graphene oxide and the combination of curing agents reads on the claimed reduced graphene oxide composition. Gao teaches a composition comprising a natural latex, a reduced graphene oxide, 0.5-5 phr of a stabilizer KOH (i.e. pH adjuster), 0.2-2 phr of an accelerator of zinc diethyl dithiocarbamate, 0.5-5 phr of a vulcanizing activator of zinc oxide, and 1-2 phr of a curing agent sulfur, 0.5-3 phr of an antioxidant (lines 54-60, 71-73, 88-106). Claim Rejections - 35 USC § 103 Claim 24 is/are rejected under 35 U.S.C. 103 as being unpatentable over Gao et al (CN105906854) in view of Wang et al (US 2002/0173563). Gao teaches the limitation of claim 20, as discussed above. Gao further teaches an excellent tensile strength is desired (1:27). Goa does not teach the composition further comprises a thiazole compound. However, Wang teaches an accelerator comprising zinc diethyldithiocarbamate, zinc 2-mercaptobenzothiazole and diphenyl guanidine can improve tensile strength [0070]. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to include triazole and guanidine into the polyisoprene latex composition to improve tensile strength. Claim 29 is/are rejected under 35 U.S.C. 103 as being unpatentable over Gao et al (CN105906854) in view of Fan et al (CN105037835). Gao teaches the limitation of claim 28, as discussed above. Gao does not teach an antioxidant like claimed. However, Fan discloses a similar composition and teaches the antioxidant can be N-isopropyl-N’-phenyl phenylenediamine. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to utilize a hindered arylamine as antioxidant because it is recognized in the art it is suitable for a composition of Gao. Claims 32 is/are rejected under 35 U.S.C. 103 as being unpatentable over Gao et al (CN105906854) in view of Zheng et al (CN105237828). Gao teaches the limitation of claim 31, as discussed above. Gao does not teach a pH value like claimed. However, Zheng discloses a similar composition and teaches the composition can have a pH value of 10.5-11. Therefore, it would have been obvious to one of ordinary skill in the art at the time the invention was made to adjust the pH value like claimed because it is recognized in the art it is a suitable value for composition of Gao. Claims 33 is/are rejected under 35 U.S.C. 103 as being unpatentable over Gao et al (CN105906854). Gao teaches in the graphene modified natural latex polymer, the mass content of graphene is 0.1-10% (line 97). Case law holds that in the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976); In re Woodruff, 919 F.2d 1575, 16 USPQ2d 1934 (Fed. Cir. 1990). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the claims at issue are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); and In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on a nonstatutory double patenting ground provided the reference application or patent either is shown to be commonly owned with this application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO internet Web site contains terminal disclaimer forms which may be used. Please visit http://www.uspto.gov/forms/. The filing date of the application will determine what form should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to http://www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claim 20, 24-25 rejected on the ground of nonstatutory double patenting as being unpatentable over claims 5-7 of U.S. Patent No.11,214,664. Although the claims at issue are not identical, they are not patentably distinct from each other because ‘664 claims a composition comprising a polyisoprene latex, a stabilizer, a reduced graphene oxide and a combination of curing agents. Response to Arguments Applicant's arguments and declaration filed 12/19/2025 have been fully considered but they are not persuasive because 1) the TEM figures shows the difference between unfilled polyisoprene and filled polyisoprene, it is insufficient to demonstrate the example of Gao would be different from the filled polyisoprene of instant application. A fair comparison is between Gao’s example and the filled polyisoprene of instant application. 2) Although reaction mechanisms shown in paragraphs 8,9 and 13 of the new declaration are all hypothesis, the XPS data showing additional C-S-C and C-S-S-C bonds formed indicates GO has been bonded to sulfur. However, the instant specification discloses the reduced graphene oxide particles are connected to or crosslinked with the latex particles, and sulfur is an optional curing agent, which indicates the inventors did not realize GO has been bonded to sulfur when the application was filed. Case law has held that basic property or utility must be disclosed in application as originally filed in order for affidavit evidence of unexpected properties to be offered. In re Davies et al. 177 USPQ 381 (CCPA 1973). 3) the data is not reasonably commensurate in scope with the scope of claims. The inventive data comes from a single embodiment with specific components, amounts and reaction conditions. Case law holds that evidence is insufficient to rebut a prima facie case if not commensurate in scope with the claimed invention. In re Grasselli, 713 F.2d 731, 741, 218 USPQ 769, 777 (Fed. Cir. 1983). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any extension fee pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to WENWEN CAI whose telephone number is (571)270-3590. The examiner can normally be reached on M-F 9am-6pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Joseph Del Sole can be reached on (571)272-1130. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of an application may be obtained from the Patent Application Information Retrieval (PAIR) system. Status information for published applications may be obtained from either Private PAIR or Public PAIR. Status information for unpublished applications is available through Private PAIR only. For more information about the PAIR system, see http://pair-direct.uspto.gov. Should you have questions on access to the Private PAIR system, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative or access to the automated information system, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /WENWEN CAI/ Primary Examiner, Art Unit 1763
Read full office action

Prosecution Timeline

Show 15 earlier events
Nov 12, 2025
Applicant Interview (Telephonic)
Nov 12, 2025
Examiner Interview Summary
Dec 19, 2025
Response Filed
Dec 19, 2025
Response after Non-Final Action
Jan 28, 2026
Final Rejection mailed — §102, §103, §112
Mar 17, 2026
Request for Continued Examination
Mar 21, 2026
Response after Non-Final Action
Nov 18, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12799265
Composition Comprising Epoxy-Functional Oxazolidinone
3y 5m to grant Granted Nov 17, 2026
Patent 12799349
AQUEOUS POLYHYDROXYALKANOATE SUSPENSION AND METHOD FOR PRODUCING THE SAME
2y 2m to grant Granted Nov 17, 2026
Patent 12779495
DIELECTRIC FILM-FORMING COMPOSITION
2y 2m to grant Granted Nov 03, 2026
Patent 12767834
AQUEOUS COATING COMPOSITION AND METHOD OF PREPARING THEREOF
2y 10m to grant Granted Oct 20, 2026
Patent 12767808
CORE-SHELL-TYPE FLUORINE-BASED RESIN PARTICLES HAVING IMPROVED FLOWABILITY AND FLOCCULATION, AND PREPARATION METHOD
1y 9m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
60%
Grant Probability
79%
With Interview (+19.5%)
3y 2m (~1m remaining)
Median Time to Grant
High
PTA Risk
Based on 889 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month